UNSPSC 51383802: Naproxcinod

Commodity

Code facts

NIGP codes
1

UNSPSC codes and definitions come from the UN Development Programme (managed by GS1 US), and state and local contract opportunities from the governments' procurement sites.

NIGP codes for 51383802

Definition

This classification denotes a cyclooxygenase inhibitor with the molecular formula C18H21NO6, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier, V24GR4LI3I chemically known as 2-naphthaleneacetic acid, 6-methoxy-.alpha.-methyl-, 4-(nitrooxy)butyl ester, (.alpha.s)- but generally known as naproxcinod, which bears US NIH Compound Identifier 9884642. European Medicines Agency schedules Naproxcinod in its eXtended EudraVigilance Medicinal Product Dictionary or XEVMPD under Index SUB30968.

Read the full definition

The term NAPROXCINOD is an International Non-Proprietary Name or INN (see WHO INN reference publication, Volume 21, no. 1, 2007, list 57). Most nations schedule naproxcinod under HS 29209090 and SITC 51639. As of Q4 2014, NAPROXCINOD remains the US FDA Preferred Term for this commodity. Naproxcinod bears US NLM identifiers UMLS ID C0915860 and NCI Concept Code C83989. SMILES: O(C(=O)C(C1CC2C(CC1)CC(OC)CC2)C)CCCCO[N](=O)O.

About UNSPSC 51383802

UNSPSC 51383802 Naproxcinod is a Commodity code, but the recent state and local activity tagged to it does not match the pharmaceutical code's nominal scope. The single recent opportunity in the database—Seminole County, Florida's IFB60459723LAS for Naloxone and Safe Drug Deactivation Systems—concerns opioid-overdose reversal agents and drug disposal equipment, not naproxcinod (a pain and inflammation medication). State and local governments appear to be using this code inconsistently or erroneously; the opportunity itself is substantive and active, but it does not reflect demand for naproxcinod as a pharmaceutical input to procurement. The mismatch suggests either a cataloging error in the source or a broad interpretation of the code that diverges sharply from its nominal pharmaceutical classification.

Seminole County, Florida posted the IFB on June 30, 2026, with a response deadline of July 26, 2023—a date inconsistency that may indicate a legacy or archived record. The procurement seeks annual deliveries of 1,900 units of naloxone and 800 safe drug deactivation systems on a quarterly schedule to the Seminole County Community Health Building in Sanford, Florida, with a two-year initial term and a one-year renewal option. Bidders must include all shipping and delivery costs, hold appropriate insurance (workers' compensation, commercial general liability, professional liability), pass E-Verify compliance, and submit unit pricing through the county's e-Procurement Portal. The contract may be FEMA-funded, triggering federal environmental and compliance standards. No explicit set-aside or disadvantaged-enterprise designations appear in the notice. This code shows minimal recent state and local activity overall; pursuit decisions should rest on direct outreach to Seminole County or similar health and public-safety departments rather than on established market signals under this UNSPSC classification.

Quick answers

What is UNSPSC 51383802?

UNSPSC 51383802 is Naproxcinod, a commodity in UNSPSC 51000000, Pharmaceutical Products incl. Contraceptives and Vaccines.

Which NIGP codes match UNSPSC 51383802?

UNSPSC 51383802 maps to 1 NIGP code, 26928 Central Nervous System Agents (Including: Analegsic, Anticonvulsant, Antidepressant, Antihistamine, Antipsychotic and Sedative).

On GovTribe

See everything under UNSPSC 51383802

  • State & local contract opportunities, awards and contract vehicles under this code
  • Contacts who buy under this code
  • Ask GovTribe AI about this code